Global iPSC-Derived Hepatocyte-Like Cells Market Growth 2026-2032
The global iPSC-Derived Hepatocyte-Like Cells market size is predicted to grow from US$ 90.00 million in 2025 to US$ 213 million in 2032; it is expected to grow at a CAGR of 13.1% from 2026 to 2032.
iPSC-Derived Hepatocyte-Like Cells are in vitro human liver cell models generated from induced pluripotent stem cells (iPSCs) through sequential stages including definitive endoderm induction, hepatic progenitor differentiation, and hepatocyte maturation. These cells typically exhibit key hepatic functions such as albumin secretion, urea production, cytochrome P450 (CYP) enzyme activity, transporter expression, and liver-specific marker expression. They are primarily used in drug-induced liver injury (DILI) assessment, drug metabolism and enzyme induction studies, genetic and metabolic liver disease modeling, RNA/gene therapy delivery validation, and early-stage regenerative medicine research. This platform helps reduce variability and supply limitations associated with primary human hepatocytes. The overall gross margin is approximately 62%.
Demand for iPSC-derived hepatocyte-like cells is mainly driven by the pharmaceutical industry’s need for more stable and human-relevant liver models in drug development. Primary human hepatocytes are limited by donor variability, batch inconsistency, and poor long-term culture stability, while hepatoma cell lines fail to accurately recapitulate normal hepatic metabolic functions. As a result, pharmaceutical companies, CROs, and academic laboratories are increasingly adopting iPSC-derived hepatocyte-like cells for early-stage toxicity screening, CYP induction studies, chronic drug exposure testing, and disease mechanism research.
Competition is shifting from basic differentiation capability toward improvements in cellular maturity, batch-to-batch consistency, long-term functional stability, and multi-application compatibility. Leading suppliers are expanding their offerings from cryopreserved ready-to-use cells to plate-ready formats and three-dimensional liver spheroids. At the same time, they are developing disease-specific models for conditions such as MASLD, A1AT deficiency, cholestasis, and urea cycle disorders using patient-derived or gene-edited iPSC lines. Integration with high-content imaging systems, automated screening platforms, and organ-on-chip or microphysiological systems is also becoming increasingly important.
Regionally, North America, Europe, and Japan remain the core markets for research and procurement, while countries such as South Korea and China are experiencing faster growth driven by iPSC platform development, innovative drug pipelines, and policies encouraging alternatives to animal testing. In the short term, opportunities are concentrated in drug safety evaluation and liver disease modeling services. Long-term potential lies in standardized cell banks, isogenic disease models, and eventual therapeutic applications, although limitations in functional maturation, lack of unified quality standards, and high production costs remain key constraints to large-scale commercialization.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “iPSC-Derived Hepatocyte-Like Cells Industry Forecast” looks at past sales and reviews total world iPSC-Derived Hepatocyte-Like Cells sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC-Derived Hepatocyte-Like Cells sales for 2026 through 2032. With iPSC-Derived Hepatocyte-Like Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC-Derived Hepatocyte-Like Cells industry.
This Insight Report provides a comprehensive analysis of the global iPSC-Derived Hepatocyte-Like Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on iPSC-Derived Hepatocyte-Like Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC-Derived Hepatocyte-Like Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC-Derived Hepatocyte-Like Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC-Derived Hepatocyte-Like Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC-Derived Hepatocyte-Like Cells market by product type, application, key manufacturers and key regions and countries.
iPSC-Derived Hepatocyte-Like Cells are in vitro human liver cell models generated from induced pluripotent stem cells (iPSCs) through sequential stages including definitive endoderm induction, hepatic progenitor differentiation, and hepatocyte maturation. These cells typically exhibit key hepatic functions such as albumin secretion, urea production, cytochrome P450 (CYP) enzyme activity, transporter expression, and liver-specific marker expression. They are primarily used in drug-induced liver injury (DILI) assessment, drug metabolism and enzyme induction studies, genetic and metabolic liver disease modeling, RNA/gene therapy delivery validation, and early-stage regenerative medicine research. This platform helps reduce variability and supply limitations associated with primary human hepatocytes. The overall gross margin is approximately 62%.
Demand for iPSC-derived hepatocyte-like cells is mainly driven by the pharmaceutical industry’s need for more stable and human-relevant liver models in drug development. Primary human hepatocytes are limited by donor variability, batch inconsistency, and poor long-term culture stability, while hepatoma cell lines fail to accurately recapitulate normal hepatic metabolic functions. As a result, pharmaceutical companies, CROs, and academic laboratories are increasingly adopting iPSC-derived hepatocyte-like cells for early-stage toxicity screening, CYP induction studies, chronic drug exposure testing, and disease mechanism research.
Competition is shifting from basic differentiation capability toward improvements in cellular maturity, batch-to-batch consistency, long-term functional stability, and multi-application compatibility. Leading suppliers are expanding their offerings from cryopreserved ready-to-use cells to plate-ready formats and three-dimensional liver spheroids. At the same time, they are developing disease-specific models for conditions such as MASLD, A1AT deficiency, cholestasis, and urea cycle disorders using patient-derived or gene-edited iPSC lines. Integration with high-content imaging systems, automated screening platforms, and organ-on-chip or microphysiological systems is also becoming increasingly important.
Regionally, North America, Europe, and Japan remain the core markets for research and procurement, while countries such as South Korea and China are experiencing faster growth driven by iPSC platform development, innovative drug pipelines, and policies encouraging alternatives to animal testing. In the short term, opportunities are concentrated in drug safety evaluation and liver disease modeling services. Long-term potential lies in standardized cell banks, isogenic disease models, and eventual therapeutic applications, although limitations in functional maturation, lack of unified quality standards, and high production costs remain key constraints to large-scale commercialization.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “iPSC-Derived Hepatocyte-Like Cells Industry Forecast” looks at past sales and reviews total world iPSC-Derived Hepatocyte-Like Cells sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC-Derived Hepatocyte-Like Cells sales for 2026 through 2032. With iPSC-Derived Hepatocyte-Like Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC-Derived Hepatocyte-Like Cells industry.
This Insight Report provides a comprehensive analysis of the global iPSC-Derived Hepatocyte-Like Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on iPSC-Derived Hepatocyte-Like Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC-Derived Hepatocyte-Like Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC-Derived Hepatocyte-Like Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC-Derived Hepatocyte-Like Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC-Derived Hepatocyte-Like Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Cryopreserved Cell Vials
- Assay-Ready Cell Plates
- 3D Spheroids and Organoids
- Co-Culture Cell Models
- Custom Differentiated Batches
Segmentation by Functional Maturity:
- Hepatic Progenitor-Like Cells
- Standard Hepatocyte-Like Cells
- Mature Hepatocyte-Like Cells
- Enhanced Metabolism Hepatocyte-Like Cells
- Long-Term Stable Hepatocyte-Like Cells
Segmentation by Donor or Genetic Background:
- Healthy Donor Cells
- Patient-Specific Disease Cells
- Isogenic Variant Cells
- Reporter-Labeled Cells
- Custom Donor-Derived Cells
Segmentation by Culture System:
- 2D Monoculture Cells
- 3D Spheroid Cells
- Liver Organoid Cells
- Microphysiological System-Ready Cells
- Hepatic Co-Culture Cells
Segmentation by Application:
- Drug-Induced Liver Injury Testing
- Drug Metabolism and CYP Induction
- Liver Disease Modeling
- RNA and Gene Therapy Delivery Studies
- Regenerative Medicine Research
- Basic Liver Biology Research
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- FUJIFILM Cellular Dynamics
- REPROCELL
- Takara Bio
- Pixl Bio
- NEXEL
- bit.bio
- AcceGen
- Creative Bioarray
- Creative Biolabs
- Cyagen
Key Questions Addressed in this Report
- What is the 10-year outlook for the global iPSC-Derived Hepatocyte-Like Cells market?
- What factors are driving iPSC-Derived Hepatocyte-Like Cells market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do iPSC-Derived Hepatocyte-Like Cells market opportunities vary by end market size?
- How does iPSC-Derived Hepatocyte-Like Cells break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for iPSC-Derived Hepatocyte-Like Cells by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for iPSC-Derived Hepatocyte-Like Cells by Country/Region, 2021, 2025 & 2032
2.2 iPSC-Derived Hepatocyte-Like Cells Segment by Type
2.2.1 Cryopreserved Cell Vials
2.2.2 Assay-Ready Cell Plates
2.2.3 3D Spheroids and Organoids
2.2.4 Co-Culture Cell Models
2.2.5 Custom Differentiated Batches
2.2.6 iPSC-Derived Hepatocyte-Like Cells Sales by Type
2.2.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
2.2.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Type (2021-2026)
2.3 iPSC-Derived Hepatocyte-Like Cells Segment by Functional Maturity
2.3.1 Hepatic Progenitor-Like Cells
2.3.2 Standard Hepatocyte-Like Cells
2.3.3 Mature Hepatocyte-Like Cells
2.3.4 Enhanced Metabolism Hepatocyte-Like Cells
2.3.5 Long-Term Stable Hepatocyte-Like Cells
2.3.6 iPSC-Derived Hepatocyte-Like Cells Sales by Functional Maturity
2.3.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Functional Maturity (2021-2026)
2.3.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Functional Maturity (2021-2026)
2.3.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Functional Maturity (2021-2026)
2.4 iPSC-Derived Hepatocyte-Like Cells Segment by Donor or Genetic Background
2.4.1 Healthy Donor Cells
2.4.2 Patient-Specific Disease Cells
2.4.3 Isogenic Variant Cells
2.4.4 Reporter-Labeled Cells
2.4.5 Custom Donor-Derived Cells
2.4.6 iPSC-Derived Hepatocyte-Like Cells Sales by Donor or Genetic Background
2.4.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Donor or Genetic Background (2021-2026)
2.4.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Donor or Genetic Background (2021-2026)
2.4.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Donor or Genetic Background (2021-2026)
2.5 iPSC-Derived Hepatocyte-Like Cells Segment by Culture System
2.5.1 2D Monoculture Cells
2.5.2 3D Spheroid Cells
2.5.3 Liver Organoid Cells
2.5.4 Microphysiological System-Ready Cells
2.5.5 Hepatic Co-Culture Cells
2.5.6 iPSC-Derived Hepatocyte-Like Cells Sales by Culture System
2.5.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Culture System (2021-2026)
2.5.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Culture System (2021-2026)
2.5.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Culture System (2021-2026)
2.6 iPSC-Derived Hepatocyte-Like Cells Segment by Application
2.6.1 Drug-Induced Liver Injury Testing
2.6.2 Drug Metabolism and CYP Induction
2.6.3 Liver Disease Modeling
2.6.4 RNA and Gene Therapy Delivery Studies
2.6.5 Regenerative Medicine Research
2.6.6 Basic Liver Biology Research
2.6.7 iPSC-Derived Hepatocyte-Like Cells Sales by Application
2.6.7.1 Global iPSC-Derived Hepatocyte-Like Cells Sale Market Share by Application (2021-2026)
2.6.7.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Application (2021-2026)
2.6.7.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global iPSC-Derived Hepatocyte-Like Cells Breakdown Data by Company
3.1.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales by Company (2021-2026)
3.1.2 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Company (2021-2026)
3.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue by Company (2021-2026)
3.2.1 Global iPSC-Derived Hepatocyte-Like Cells Revenue by Company (2021-2026)
3.2.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Company (2021-2026)
3.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Company
3.4 Key Manufacturers iPSC-Derived Hepatocyte-Like Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers iPSC-Derived Hepatocyte-Like Cells Product Location Distribution
3.4.2 Players iPSC-Derived Hepatocyte-Like Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IPSC-DERIVED HEPATOCYTE-LIKE CELLS BY GEOGRAPHIC REGION
4.1 World Historic iPSC-Derived Hepatocyte-Like Cells Market Size by Geographic Region (2021-2026)
4.1.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales by Geographic Region (2021-2026)
4.1.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic iPSC-Derived Hepatocyte-Like Cells Market Size by Country/Region (2021-2026)
4.2.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales by Country/Region (2021-2026)
4.2.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC-Derived Hepatocyte-Like Cells Sales Growth
4.4 APAC iPSC-Derived Hepatocyte-Like Cells Sales Growth
4.5 Europe iPSC-Derived Hepatocyte-Like Cells Sales Growth
4.6 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Growth
5 AMERICAS
5.1 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Country
5.1.1 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026)
5.1.2 Americas iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026)
5.2 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
5.3 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Region
6.1.1 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Region (2021-2026)
6.1.2 APAC iPSC-Derived Hepatocyte-Like Cells Revenue by Region (2021-2026)
6.2 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
6.3 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe iPSC-Derived Hepatocyte-Like Cells by Country
7.1.1 Europe iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026)
7.1.2 Europe iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026)
7.2 Europe iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
7.3 Europe iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells by Country
8.1.1 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026)
8.1.2 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026)
8.2 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
8.3 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of iPSC-Derived Hepatocyte-Like Cells
10.3 Manufacturing Process Analysis of iPSC-Derived Hepatocyte-Like Cells
10.4 Industry Chain Structure of iPSC-Derived Hepatocyte-Like Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 iPSC-Derived Hepatocyte-Like Cells Distributors
11.3 iPSC-Derived Hepatocyte-Like Cells Customer
12 WORLD FORECAST REVIEW FOR IPSC-DERIVED HEPATOCYTE-LIKE CELLS BY GEOGRAPHIC REGION
12.1 Global iPSC-Derived Hepatocyte-Like Cells Market Size Forecast by Region
12.1.1 Global iPSC-Derived Hepatocyte-Like Cells Forecast by Region (2027-2032)
12.1.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global iPSC-Derived Hepatocyte-Like Cells Forecast by Type (2027-2032)
12.7 Global iPSC-Derived Hepatocyte-Like Cells Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 FUJIFILM Cellular Dynamics
13.1.1 FUJIFILM Cellular Dynamics Company Information
13.1.2 FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.1.3 FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 FUJIFILM Cellular Dynamics Main Business Overview
13.1.5 FUJIFILM Cellular Dynamics Latest Developments
13.2 REPROCELL
13.2.1 REPROCELL Company Information
13.2.2 REPROCELL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.2.3 REPROCELL iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 REPROCELL Main Business Overview
13.2.5 REPROCELL Latest Developments
13.3 Takara Bio
13.3.1 Takara Bio Company Information
13.3.2 Takara Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.3.3 Takara Bio iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takara Bio Main Business Overview
13.3.5 Takara Bio Latest Developments
13.4 Pixl Bio
13.4.1 Pixl Bio Company Information
13.4.2 Pixl Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.4.3 Pixl Bio iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pixl Bio Main Business Overview
13.4.5 Pixl Bio Latest Developments
13.5 NEXEL
13.5.1 NEXEL Company Information
13.5.2 NEXEL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.5.3 NEXEL iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NEXEL Main Business Overview
13.5.5 NEXEL Latest Developments
13.6 bit.bio
13.6.1 bit.bio Company Information
13.6.2 bit.bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.6.3 bit.bio iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 bit.bio Main Business Overview
13.6.5 bit.bio Latest Developments
13.7 AcceGen
13.7.1 AcceGen Company Information
13.7.2 AcceGen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.7.3 AcceGen iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AcceGen Main Business Overview
13.7.5 AcceGen Latest Developments
13.8 Creative Bioarray
13.8.1 Creative Bioarray Company Information
13.8.2 Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.8.3 Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Creative Bioarray Main Business Overview
13.8.5 Creative Bioarray Latest Developments
13.9 Creative Biolabs
13.9.1 Creative Biolabs Company Information
13.9.2 Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.9.3 Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Creative Biolabs Main Business Overview
13.9.5 Creative Biolabs Latest Developments
13.10 Cyagen
13.10.1 Cyagen Company Information
13.10.2 Cyagen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.10.3 Cyagen iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Cyagen Main Business Overview
13.10.5 Cyagen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for iPSC-Derived Hepatocyte-Like Cells by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for iPSC-Derived Hepatocyte-Like Cells by Country/Region, 2021, 2025 & 2032
2.2 iPSC-Derived Hepatocyte-Like Cells Segment by Type
2.2.1 Cryopreserved Cell Vials
2.2.2 Assay-Ready Cell Plates
2.2.3 3D Spheroids and Organoids
2.2.4 Co-Culture Cell Models
2.2.5 Custom Differentiated Batches
2.2.6 iPSC-Derived Hepatocyte-Like Cells Sales by Type
2.2.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
2.2.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Type (2021-2026)
2.3 iPSC-Derived Hepatocyte-Like Cells Segment by Functional Maturity
2.3.1 Hepatic Progenitor-Like Cells
2.3.2 Standard Hepatocyte-Like Cells
2.3.3 Mature Hepatocyte-Like Cells
2.3.4 Enhanced Metabolism Hepatocyte-Like Cells
2.3.5 Long-Term Stable Hepatocyte-Like Cells
2.3.6 iPSC-Derived Hepatocyte-Like Cells Sales by Functional Maturity
2.3.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Functional Maturity (2021-2026)
2.3.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Functional Maturity (2021-2026)
2.3.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Functional Maturity (2021-2026)
2.4 iPSC-Derived Hepatocyte-Like Cells Segment by Donor or Genetic Background
2.4.1 Healthy Donor Cells
2.4.2 Patient-Specific Disease Cells
2.4.3 Isogenic Variant Cells
2.4.4 Reporter-Labeled Cells
2.4.5 Custom Donor-Derived Cells
2.4.6 iPSC-Derived Hepatocyte-Like Cells Sales by Donor or Genetic Background
2.4.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Donor or Genetic Background (2021-2026)
2.4.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Donor or Genetic Background (2021-2026)
2.4.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Donor or Genetic Background (2021-2026)
2.5 iPSC-Derived Hepatocyte-Like Cells Segment by Culture System
2.5.1 2D Monoculture Cells
2.5.2 3D Spheroid Cells
2.5.3 Liver Organoid Cells
2.5.4 Microphysiological System-Ready Cells
2.5.5 Hepatic Co-Culture Cells
2.5.6 iPSC-Derived Hepatocyte-Like Cells Sales by Culture System
2.5.6.1 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Culture System (2021-2026)
2.5.6.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Culture System (2021-2026)
2.5.6.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Culture System (2021-2026)
2.6 iPSC-Derived Hepatocyte-Like Cells Segment by Application
2.6.1 Drug-Induced Liver Injury Testing
2.6.2 Drug Metabolism and CYP Induction
2.6.3 Liver Disease Modeling
2.6.4 RNA and Gene Therapy Delivery Studies
2.6.5 Regenerative Medicine Research
2.6.6 Basic Liver Biology Research
2.6.7 iPSC-Derived Hepatocyte-Like Cells Sales by Application
2.6.7.1 Global iPSC-Derived Hepatocyte-Like Cells Sale Market Share by Application (2021-2026)
2.6.7.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue and Market Share by Application (2021-2026)
2.6.7.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global iPSC-Derived Hepatocyte-Like Cells Breakdown Data by Company
3.1.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales by Company (2021-2026)
3.1.2 Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Company (2021-2026)
3.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue by Company (2021-2026)
3.2.1 Global iPSC-Derived Hepatocyte-Like Cells Revenue by Company (2021-2026)
3.2.2 Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Company (2021-2026)
3.3 Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Company
3.4 Key Manufacturers iPSC-Derived Hepatocyte-Like Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers iPSC-Derived Hepatocyte-Like Cells Product Location Distribution
3.4.2 Players iPSC-Derived Hepatocyte-Like Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IPSC-DERIVED HEPATOCYTE-LIKE CELLS BY GEOGRAPHIC REGION
4.1 World Historic iPSC-Derived Hepatocyte-Like Cells Market Size by Geographic Region (2021-2026)
4.1.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales by Geographic Region (2021-2026)
4.1.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic iPSC-Derived Hepatocyte-Like Cells Market Size by Country/Region (2021-2026)
4.2.1 Global iPSC-Derived Hepatocyte-Like Cells Annual Sales by Country/Region (2021-2026)
4.2.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC-Derived Hepatocyte-Like Cells Sales Growth
4.4 APAC iPSC-Derived Hepatocyte-Like Cells Sales Growth
4.5 Europe iPSC-Derived Hepatocyte-Like Cells Sales Growth
4.6 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Growth
5 AMERICAS
5.1 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Country
5.1.1 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026)
5.1.2 Americas iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026)
5.2 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
5.3 Americas iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Region
6.1.1 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Region (2021-2026)
6.1.2 APAC iPSC-Derived Hepatocyte-Like Cells Revenue by Region (2021-2026)
6.2 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
6.3 APAC iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe iPSC-Derived Hepatocyte-Like Cells by Country
7.1.1 Europe iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026)
7.1.2 Europe iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026)
7.2 Europe iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
7.3 Europe iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells by Country
8.1.1 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026)
8.1.2 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026)
8.2 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026)
8.3 Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of iPSC-Derived Hepatocyte-Like Cells
10.3 Manufacturing Process Analysis of iPSC-Derived Hepatocyte-Like Cells
10.4 Industry Chain Structure of iPSC-Derived Hepatocyte-Like Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 iPSC-Derived Hepatocyte-Like Cells Distributors
11.3 iPSC-Derived Hepatocyte-Like Cells Customer
12 WORLD FORECAST REVIEW FOR IPSC-DERIVED HEPATOCYTE-LIKE CELLS BY GEOGRAPHIC REGION
12.1 Global iPSC-Derived Hepatocyte-Like Cells Market Size Forecast by Region
12.1.1 Global iPSC-Derived Hepatocyte-Like Cells Forecast by Region (2027-2032)
12.1.2 Global iPSC-Derived Hepatocyte-Like Cells Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global iPSC-Derived Hepatocyte-Like Cells Forecast by Type (2027-2032)
12.7 Global iPSC-Derived Hepatocyte-Like Cells Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 FUJIFILM Cellular Dynamics
13.1.1 FUJIFILM Cellular Dynamics Company Information
13.1.2 FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.1.3 FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 FUJIFILM Cellular Dynamics Main Business Overview
13.1.5 FUJIFILM Cellular Dynamics Latest Developments
13.2 REPROCELL
13.2.1 REPROCELL Company Information
13.2.2 REPROCELL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.2.3 REPROCELL iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 REPROCELL Main Business Overview
13.2.5 REPROCELL Latest Developments
13.3 Takara Bio
13.3.1 Takara Bio Company Information
13.3.2 Takara Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.3.3 Takara Bio iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takara Bio Main Business Overview
13.3.5 Takara Bio Latest Developments
13.4 Pixl Bio
13.4.1 Pixl Bio Company Information
13.4.2 Pixl Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.4.3 Pixl Bio iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pixl Bio Main Business Overview
13.4.5 Pixl Bio Latest Developments
13.5 NEXEL
13.5.1 NEXEL Company Information
13.5.2 NEXEL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.5.3 NEXEL iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NEXEL Main Business Overview
13.5.5 NEXEL Latest Developments
13.6 bit.bio
13.6.1 bit.bio Company Information
13.6.2 bit.bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.6.3 bit.bio iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 bit.bio Main Business Overview
13.6.5 bit.bio Latest Developments
13.7 AcceGen
13.7.1 AcceGen Company Information
13.7.2 AcceGen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.7.3 AcceGen iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AcceGen Main Business Overview
13.7.5 AcceGen Latest Developments
13.8 Creative Bioarray
13.8.1 Creative Bioarray Company Information
13.8.2 Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.8.3 Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Creative Bioarray Main Business Overview
13.8.5 Creative Bioarray Latest Developments
13.9 Creative Biolabs
13.9.1 Creative Biolabs Company Information
13.9.2 Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.9.3 Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Creative Biolabs Main Business Overview
13.9.5 Creative Biolabs Latest Developments
13.10 Cyagen
13.10.1 Cyagen Company Information
13.10.2 Cyagen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
13.10.3 Cyagen iPSC-Derived Hepatocyte-Like Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Cyagen Main Business Overview
13.10.5 Cyagen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. iPSC-Derived Hepatocyte-Like Cells Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. iPSC-Derived Hepatocyte-Like Cells Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cryopreserved Cell Vials
Table 4. Major Players of Assay-Ready Cell Plates
Table 5. Major Players of 3D Spheroids and Organoids
Table 6. Major Players of Co-Culture Cell Models
Table 7. Major Players of Custom Differentiated Batches
Table 8. Global iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 9. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Table 10. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Type (2021-2026) & ($ million)
Table 11. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Type (2021-2026)
Table 12. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Type (2021-2026) & (US$/mL)
Table 13. Major Players of Hepatic Progenitor-Like Cells
Table 14. Major Players of Standard Hepatocyte-Like Cells
Table 15. Major Players of Mature Hepatocyte-Like Cells
Table 16. Major Players of Enhanced Metabolism Hepatocyte-Like Cells
Table 17. Major Players of Long-Term Stable Hepatocyte-Like Cells
Table 18. Global iPSC-Derived Hepatocyte-Like Cells Sales by Functional Maturity (2021-2026) & (L)
Table 19. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Functional Maturity (2021-2026)
Table 20. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Functional Maturity (2021-2026) & ($ million)
Table 21. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Functional Maturity (2021-2026)
Table 22. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Functional Maturity (2021-2026) & (US$/mL)
Table 23. Major Players of Healthy Donor Cells
Table 24. Major Players of Patient-Specific Disease Cells
Table 25. Major Players of Isogenic Variant Cells
Table 26. Major Players of Reporter-Labeled Cells
Table 27. Major Players of Custom Donor-Derived Cells
Table 28. Global iPSC-Derived Hepatocyte-Like Cells Sales by Donor or Genetic Background (2021-2026) & (L)
Table 29. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Donor or Genetic Background (2021-2026)
Table 30. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Donor or Genetic Background (2021-2026) & ($ million)
Table 31. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Donor or Genetic Background (2021-2026)
Table 32. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Donor or Genetic Background (2021-2026) & (US$/mL)
Table 33. Major Players of 2D Monoculture Cells
Table 34. Major Players of 3D Spheroid Cells
Table 35. Major Players of Liver Organoid Cells
Table 36. Major Players of Microphysiological System-Ready Cells
Table 37. Major Players of Hepatic Co-Culture Cells
Table 38. Global iPSC-Derived Hepatocyte-Like Cells Sales by Culture System (2021-2026) & (L)
Table 39. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Culture System (2021-2026)
Table 40. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Culture System (2021-2026) & ($ million)
Table 41. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Culture System (2021-2026)
Table 42. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Culture System (2021-2026) & (US$/mL)
Table 43. Global iPSC-Derived Hepatocyte-Like Cells Sale by Application (2021-2026) & (L)
Table 44. Global iPSC-Derived Hepatocyte-Like Cells Sale Market Share by Application (2021-2026)
Table 45. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Application (2021-2026) & ($ million)
Table 46. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Application (2021-2026)
Table 47. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Application (2021-2026) & (US$/mL)
Table 48. Global iPSC-Derived Hepatocyte-Like Cells Sales by Company (2021-2026) & (L)
Table 49. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Company (2021-2026)
Table 50. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Company (2021-2026) & ($ millions)
Table 51. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Company (2021-2026)
Table 52. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Company (2021-2026) & (US$/mL)
Table 53. Key Manufacturers iPSC-Derived Hepatocyte-Like Cells Producing Area Distribution and Sales Area
Table 54. Players iPSC-Derived Hepatocyte-Like Cells Products Offered
Table 55. iPSC-Derived Hepatocyte-Like Cells Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 56. New Products and Potential Entrants
Table 57. Market M&A Activity & Strategy
Table 58. Global iPSC-Derived Hepatocyte-Like Cells Sales by Geographic Region (2021-2026) & (L)
Table 59. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share Geographic Region (2021-2026)
Table 60. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Geographic Region (2021-2026) & ($ millions)
Table 61. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Geographic Region (2021-2026)
Table 62. Global iPSC-Derived Hepatocyte-Like Cells Sales by Country/Region (2021-2026) & (L)
Table 63. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country/Region (2021-2026)
Table 64. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Country/Region (2021-2026) & ($ millions)
Table 65. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country/Region (2021-2026)
Table 66. Americas iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026) & (L)
Table 67. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country (2021-2026)
Table 68. Americas iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026) & ($ millions)
Table 69. Americas iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 70. Americas iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 71. APAC iPSC-Derived Hepatocyte-Like Cells Sales by Region (2021-2026) & (L)
Table 72. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Region (2021-2026)
Table 73. APAC iPSC-Derived Hepatocyte-Like Cells Revenue by Region (2021-2026) & ($ millions)
Table 74. APAC iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 75. APAC iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 76. Europe iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026) & (L)
Table 77. Europe iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026) & ($ millions)
Table 78. Europe iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 79. Europe iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 80. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026) & (L)
Table 81. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country (2021-2026)
Table 82. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 83. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 84. Key Market Drivers & Growth Opportunities of iPSC-Derived Hepatocyte-Like Cells
Table 85. Key Market Challenges & Risks of iPSC-Derived Hepatocyte-Like Cells
Table 86. Key Industry Trends of iPSC-Derived Hepatocyte-Like Cells
Table 87. iPSC-Derived Hepatocyte-Like Cells Raw Material
Table 88. Key Suppliers of Raw Materials
Table 89. iPSC-Derived Hepatocyte-Like Cells Distributors List
Table 90. iPSC-Derived Hepatocyte-Like Cells Customer List
Table 91. Global iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Region (2027-2032) & (L)
Table 92. Global iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Region (2027-2032) & ($ millions)
Table 93. Americas iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Country (2027-2032) & (L)
Table 94. Americas iPSC-Derived Hepatocyte-Like Cells Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 95. APAC iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Region (2027-2032) & (L)
Table 96. APAC iPSC-Derived Hepatocyte-Like Cells Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 97. Europe iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Country (2027-2032) & (L)
Table 98. Europe iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 99. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Country (2027-2032) & (L)
Table 100. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 101. Global iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Type (2027-2032) & (L)
Table 102. Global iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Type (2027-2032) & ($ millions)
Table 103. Global iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Application (2027-2032) & (L)
Table 104. Global iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Application (2027-2032) & ($ millions)
Table 105. FUJIFILM Cellular Dynamics Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 106. FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 107. FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 108. FUJIFILM Cellular Dynamics Main Business
Table 109. FUJIFILM Cellular Dynamics Latest Developments
Table 110. REPROCELL Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 111. REPROCELL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 112. REPROCELL iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 113. REPROCELL Main Business
Table 114. REPROCELL Latest Developments
Table 115. Takara Bio Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 116. Takara Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 117. Takara Bio iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 118. Takara Bio Main Business
Table 119. Takara Bio Latest Developments
Table 120. Pixl Bio Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 121. Pixl Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 122. Pixl Bio iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 123. Pixl Bio Main Business
Table 124. Pixl Bio Latest Developments
Table 125. NEXEL Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 126. NEXEL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 127. NEXEL iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 128. NEXEL Main Business
Table 129. NEXEL Latest Developments
Table 130. bit.bio Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 131. bit.bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 132. bit.bio iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 133. bit.bio Main Business
Table 134. bit.bio Latest Developments
Table 135. AcceGen Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 136. AcceGen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 137. AcceGen iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 138. AcceGen Main Business
Table 139. AcceGen Latest Developments
Table 140. Creative Bioarray Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 141. Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 142. Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 143. Creative Bioarray Main Business
Table 144. Creative Bioarray Latest Developments
Table 145. Creative Biolabs Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 146. Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 147. Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 148. Creative Biolabs Main Business
Table 149. Creative Biolabs Latest Developments
Table 150. Cyagen Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 151. Cyagen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 152. Cyagen iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 153. Cyagen Main Business
Table 154. Cyagen Latest Developments
Table 1. iPSC-Derived Hepatocyte-Like Cells Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. iPSC-Derived Hepatocyte-Like Cells Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cryopreserved Cell Vials
Table 4. Major Players of Assay-Ready Cell Plates
Table 5. Major Players of 3D Spheroids and Organoids
Table 6. Major Players of Co-Culture Cell Models
Table 7. Major Players of Custom Differentiated Batches
Table 8. Global iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 9. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Table 10. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Type (2021-2026) & ($ million)
Table 11. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Type (2021-2026)
Table 12. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Type (2021-2026) & (US$/mL)
Table 13. Major Players of Hepatic Progenitor-Like Cells
Table 14. Major Players of Standard Hepatocyte-Like Cells
Table 15. Major Players of Mature Hepatocyte-Like Cells
Table 16. Major Players of Enhanced Metabolism Hepatocyte-Like Cells
Table 17. Major Players of Long-Term Stable Hepatocyte-Like Cells
Table 18. Global iPSC-Derived Hepatocyte-Like Cells Sales by Functional Maturity (2021-2026) & (L)
Table 19. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Functional Maturity (2021-2026)
Table 20. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Functional Maturity (2021-2026) & ($ million)
Table 21. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Functional Maturity (2021-2026)
Table 22. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Functional Maturity (2021-2026) & (US$/mL)
Table 23. Major Players of Healthy Donor Cells
Table 24. Major Players of Patient-Specific Disease Cells
Table 25. Major Players of Isogenic Variant Cells
Table 26. Major Players of Reporter-Labeled Cells
Table 27. Major Players of Custom Donor-Derived Cells
Table 28. Global iPSC-Derived Hepatocyte-Like Cells Sales by Donor or Genetic Background (2021-2026) & (L)
Table 29. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Donor or Genetic Background (2021-2026)
Table 30. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Donor or Genetic Background (2021-2026) & ($ million)
Table 31. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Donor or Genetic Background (2021-2026)
Table 32. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Donor or Genetic Background (2021-2026) & (US$/mL)
Table 33. Major Players of 2D Monoculture Cells
Table 34. Major Players of 3D Spheroid Cells
Table 35. Major Players of Liver Organoid Cells
Table 36. Major Players of Microphysiological System-Ready Cells
Table 37. Major Players of Hepatic Co-Culture Cells
Table 38. Global iPSC-Derived Hepatocyte-Like Cells Sales by Culture System (2021-2026) & (L)
Table 39. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Culture System (2021-2026)
Table 40. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Culture System (2021-2026) & ($ million)
Table 41. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Culture System (2021-2026)
Table 42. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Culture System (2021-2026) & (US$/mL)
Table 43. Global iPSC-Derived Hepatocyte-Like Cells Sale by Application (2021-2026) & (L)
Table 44. Global iPSC-Derived Hepatocyte-Like Cells Sale Market Share by Application (2021-2026)
Table 45. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Application (2021-2026) & ($ million)
Table 46. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Application (2021-2026)
Table 47. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Application (2021-2026) & (US$/mL)
Table 48. Global iPSC-Derived Hepatocyte-Like Cells Sales by Company (2021-2026) & (L)
Table 49. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Company (2021-2026)
Table 50. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Company (2021-2026) & ($ millions)
Table 51. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Company (2021-2026)
Table 52. Global iPSC-Derived Hepatocyte-Like Cells Sale Price by Company (2021-2026) & (US$/mL)
Table 53. Key Manufacturers iPSC-Derived Hepatocyte-Like Cells Producing Area Distribution and Sales Area
Table 54. Players iPSC-Derived Hepatocyte-Like Cells Products Offered
Table 55. iPSC-Derived Hepatocyte-Like Cells Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 56. New Products and Potential Entrants
Table 57. Market M&A Activity & Strategy
Table 58. Global iPSC-Derived Hepatocyte-Like Cells Sales by Geographic Region (2021-2026) & (L)
Table 59. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share Geographic Region (2021-2026)
Table 60. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Geographic Region (2021-2026) & ($ millions)
Table 61. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Geographic Region (2021-2026)
Table 62. Global iPSC-Derived Hepatocyte-Like Cells Sales by Country/Region (2021-2026) & (L)
Table 63. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country/Region (2021-2026)
Table 64. Global iPSC-Derived Hepatocyte-Like Cells Revenue by Country/Region (2021-2026) & ($ millions)
Table 65. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country/Region (2021-2026)
Table 66. Americas iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026) & (L)
Table 67. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country (2021-2026)
Table 68. Americas iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026) & ($ millions)
Table 69. Americas iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 70. Americas iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 71. APAC iPSC-Derived Hepatocyte-Like Cells Sales by Region (2021-2026) & (L)
Table 72. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Region (2021-2026)
Table 73. APAC iPSC-Derived Hepatocyte-Like Cells Revenue by Region (2021-2026) & ($ millions)
Table 74. APAC iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 75. APAC iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 76. Europe iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026) & (L)
Table 77. Europe iPSC-Derived Hepatocyte-Like Cells Revenue by Country (2021-2026) & ($ millions)
Table 78. Europe iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 79. Europe iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 80. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Country (2021-2026) & (L)
Table 81. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country (2021-2026)
Table 82. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Type (2021-2026) & (L)
Table 83. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales by Application (2021-2026) & (L)
Table 84. Key Market Drivers & Growth Opportunities of iPSC-Derived Hepatocyte-Like Cells
Table 85. Key Market Challenges & Risks of iPSC-Derived Hepatocyte-Like Cells
Table 86. Key Industry Trends of iPSC-Derived Hepatocyte-Like Cells
Table 87. iPSC-Derived Hepatocyte-Like Cells Raw Material
Table 88. Key Suppliers of Raw Materials
Table 89. iPSC-Derived Hepatocyte-Like Cells Distributors List
Table 90. iPSC-Derived Hepatocyte-Like Cells Customer List
Table 91. Global iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Region (2027-2032) & (L)
Table 92. Global iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Region (2027-2032) & ($ millions)
Table 93. Americas iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Country (2027-2032) & (L)
Table 94. Americas iPSC-Derived Hepatocyte-Like Cells Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 95. APAC iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Region (2027-2032) & (L)
Table 96. APAC iPSC-Derived Hepatocyte-Like Cells Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 97. Europe iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Country (2027-2032) & (L)
Table 98. Europe iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 99. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Country (2027-2032) & (L)
Table 100. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 101. Global iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Type (2027-2032) & (L)
Table 102. Global iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Type (2027-2032) & ($ millions)
Table 103. Global iPSC-Derived Hepatocyte-Like Cells Sales Forecast by Application (2027-2032) & (L)
Table 104. Global iPSC-Derived Hepatocyte-Like Cells Revenue Forecast by Application (2027-2032) & ($ millions)
Table 105. FUJIFILM Cellular Dynamics Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 106. FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 107. FUJIFILM Cellular Dynamics iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 108. FUJIFILM Cellular Dynamics Main Business
Table 109. FUJIFILM Cellular Dynamics Latest Developments
Table 110. REPROCELL Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 111. REPROCELL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 112. REPROCELL iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 113. REPROCELL Main Business
Table 114. REPROCELL Latest Developments
Table 115. Takara Bio Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 116. Takara Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 117. Takara Bio iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 118. Takara Bio Main Business
Table 119. Takara Bio Latest Developments
Table 120. Pixl Bio Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 121. Pixl Bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 122. Pixl Bio iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 123. Pixl Bio Main Business
Table 124. Pixl Bio Latest Developments
Table 125. NEXEL Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 126. NEXEL iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 127. NEXEL iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 128. NEXEL Main Business
Table 129. NEXEL Latest Developments
Table 130. bit.bio Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 131. bit.bio iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 132. bit.bio iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 133. bit.bio Main Business
Table 134. bit.bio Latest Developments
Table 135. AcceGen Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 136. AcceGen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 137. AcceGen iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 138. AcceGen Main Business
Table 139. AcceGen Latest Developments
Table 140. Creative Bioarray Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 141. Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 142. Creative Bioarray iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 143. Creative Bioarray Main Business
Table 144. Creative Bioarray Latest Developments
Table 145. Creative Biolabs Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 146. Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 147. Creative Biolabs iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 148. Creative Biolabs Main Business
Table 149. Creative Biolabs Latest Developments
Table 150. Cyagen Basic Information, iPSC-Derived Hepatocyte-Like Cells Manufacturing Base, Sales Area and Its Competitors
Table 151. Cyagen iPSC-Derived Hepatocyte-Like Cells Product Portfolios and Specifications
Table 152. Cyagen iPSC-Derived Hepatocyte-Like Cells Sales (L), Revenue ($ Million), Price (US$/mL) and Gross Margin (2021-2026)
Table 153. Cyagen Main Business
Table 154. Cyagen Latest Developments
LIST OF FIGURES
Figure 1. Picture of iPSC-Derived Hepatocyte-Like Cells
Figure 2. iPSC-Derived Hepatocyte-Like Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global iPSC-Derived Hepatocyte-Like Cells Sales Growth Rate 2021-2032 (L)
Figure 7. Global iPSC-Derived Hepatocyte-Like Cells Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. iPSC-Derived Hepatocyte-Like Cells Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country/Region (2025)
Figure 10. iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cryopreserved Cell Vials
Figure 12. Product Picture of Assay-Ready Cell Plates
Figure 13. Product Picture of 3D Spheroids and Organoids
Figure 14. Product Picture of Co-Culture Cell Models
Figure 15. Product Picture of Custom Differentiated Batches
Figure 16. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type in 2026
Figure 17. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Hepatic Progenitor-Like Cells
Figure 19. Product Picture of Standard Hepatocyte-Like Cells
Figure 20. Product Picture of Mature Hepatocyte-Like Cells
Figure 21. Product Picture of Enhanced Metabolism Hepatocyte-Like Cells
Figure 22. Product Picture of Long-Term Stable Hepatocyte-Like Cells
Figure 23. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Functional Maturity in 2026
Figure 24. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Functional Maturity (2021-2026)
Figure 25. Product Picture of Healthy Donor Cells
Figure 26. Product Picture of Patient-Specific Disease Cells
Figure 27. Product Picture of Isogenic Variant Cells
Figure 28. Product Picture of Reporter-Labeled Cells
Figure 29. Product Picture of Custom Donor-Derived Cells
Figure 30. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Donor or Genetic Background in 2026
Figure 31. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Donor or Genetic Background (2021-2026)
Figure 32. Product Picture of 2D Monoculture Cells
Figure 33. Product Picture of 3D Spheroid Cells
Figure 34. Product Picture of Liver Organoid Cells
Figure 35. Product Picture of Microphysiological System-Ready Cells
Figure 36. Product Picture of Hepatic Co-Culture Cells
Figure 37. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Culture System in 2026
Figure 38. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Culture System (2021-2026)
Figure 39. iPSC-Derived Hepatocyte-Like Cells Consumed in Drug-Induced Liver Injury Testing
Figure 40. Global iPSC-Derived Hepatocyte-Like Cells Market: Drug-Induced Liver Injury Testing (2021-2026) & (L)
Figure 41. iPSC-Derived Hepatocyte-Like Cells Consumed in Drug Metabolism and CYP Induction
Figure 42. Global iPSC-Derived Hepatocyte-Like Cells Market: Drug Metabolism and CYP Induction (2021-2026) & (L)
Figure 43. iPSC-Derived Hepatocyte-Like Cells Consumed in Liver Disease Modeling
Figure 44. Global iPSC-Derived Hepatocyte-Like Cells Market: Liver Disease Modeling (2021-2026) & (L)
Figure 45. iPSC-Derived Hepatocyte-Like Cells Consumed in RNA and Gene Therapy Delivery Studies
Figure 46. Global iPSC-Derived Hepatocyte-Like Cells Market: RNA and Gene Therapy Delivery Studies (2021-2026) & (L)
Figure 47. iPSC-Derived Hepatocyte-Like Cells Consumed in Regenerative Medicine Research
Figure 48. Global iPSC-Derived Hepatocyte-Like Cells Market: Regenerative Medicine Research (2021-2026) & (L)
Figure 49. iPSC-Derived Hepatocyte-Like Cells Consumed in Basic Liver Biology Research
Figure 50. Global iPSC-Derived Hepatocyte-Like Cells Market: Basic Liver Biology Research (2021-2026) & (L)
Figure 51. Global iPSC-Derived Hepatocyte-Like Cells Sale Market Share by Application (2025)
Figure 52. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Application in 2025
Figure 53. iPSC-Derived Hepatocyte-Like Cells Sales by Company in 2025 (L)
Figure 54. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Company in 2025
Figure 55. iPSC-Derived Hepatocyte-Like Cells Revenue by Company in 2025 ($ millions)
Figure 56. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Company in 2025
Figure 57. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Geographic Region (2021-2026)
Figure 58. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Geographic Region in 2025
Figure 59. Americas iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 60. Americas iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 61. APAC iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 62. APAC iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 63. Europe iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 64. Europe iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 65. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 66. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 67. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country in 2025
Figure 68. Americas iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country (2021-2026)
Figure 69. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 70. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 71. United States iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 72. Canada iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 73. Mexico iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 74. Brazil iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 75. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Region in 2025
Figure 76. APAC iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Region (2021-2026)
Figure 77. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 78. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 79. China iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 80. Japan iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 81. South Korea iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 82. Southeast Asia iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 83. India iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 84. Australia iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 85. China Taiwan iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 86. Europe iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country in 2025
Figure 87. Europe iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country (2021-2026)
Figure 88. Europe iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 89. Europe iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 90. Germany iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 91. France iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 92. UK iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 93. Italy iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 94. Russia iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 95. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country (2021-2026)
Figure 96. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 97. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 98. Egypt iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 99. South Africa iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 100. Israel iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 101. Turkey iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 102. GCC Countries iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 103. Manufacturing Cost Structure Analysis of iPSC-Derived Hepatocyte-Like Cells in 2026
Figure 104. Manufacturing Process Analysis of iPSC-Derived Hepatocyte-Like Cells
Figure 105. Industry Chain Structure of iPSC-Derived Hepatocyte-Like Cells
Figure 106. Channels of Distribution
Figure 107. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Forecast by Region (2027-2032)
Figure 108. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share Forecast by Region (2027-2032)
Figure 109. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share Forecast by Type (2027-2032)
Figure 110. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share Forecast by Type (2027-2032)
Figure 111. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share Forecast by Application (2027-2032)
Figure 112. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of iPSC-Derived Hepatocyte-Like Cells
Figure 2. iPSC-Derived Hepatocyte-Like Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global iPSC-Derived Hepatocyte-Like Cells Sales Growth Rate 2021-2032 (L)
Figure 7. Global iPSC-Derived Hepatocyte-Like Cells Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. iPSC-Derived Hepatocyte-Like Cells Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country/Region (2025)
Figure 10. iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cryopreserved Cell Vials
Figure 12. Product Picture of Assay-Ready Cell Plates
Figure 13. Product Picture of 3D Spheroids and Organoids
Figure 14. Product Picture of Co-Culture Cell Models
Figure 15. Product Picture of Custom Differentiated Batches
Figure 16. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type in 2026
Figure 17. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Hepatic Progenitor-Like Cells
Figure 19. Product Picture of Standard Hepatocyte-Like Cells
Figure 20. Product Picture of Mature Hepatocyte-Like Cells
Figure 21. Product Picture of Enhanced Metabolism Hepatocyte-Like Cells
Figure 22. Product Picture of Long-Term Stable Hepatocyte-Like Cells
Figure 23. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Functional Maturity in 2026
Figure 24. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Functional Maturity (2021-2026)
Figure 25. Product Picture of Healthy Donor Cells
Figure 26. Product Picture of Patient-Specific Disease Cells
Figure 27. Product Picture of Isogenic Variant Cells
Figure 28. Product Picture of Reporter-Labeled Cells
Figure 29. Product Picture of Custom Donor-Derived Cells
Figure 30. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Donor or Genetic Background in 2026
Figure 31. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Donor or Genetic Background (2021-2026)
Figure 32. Product Picture of 2D Monoculture Cells
Figure 33. Product Picture of 3D Spheroid Cells
Figure 34. Product Picture of Liver Organoid Cells
Figure 35. Product Picture of Microphysiological System-Ready Cells
Figure 36. Product Picture of Hepatic Co-Culture Cells
Figure 37. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Culture System in 2026
Figure 38. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Culture System (2021-2026)
Figure 39. iPSC-Derived Hepatocyte-Like Cells Consumed in Drug-Induced Liver Injury Testing
Figure 40. Global iPSC-Derived Hepatocyte-Like Cells Market: Drug-Induced Liver Injury Testing (2021-2026) & (L)
Figure 41. iPSC-Derived Hepatocyte-Like Cells Consumed in Drug Metabolism and CYP Induction
Figure 42. Global iPSC-Derived Hepatocyte-Like Cells Market: Drug Metabolism and CYP Induction (2021-2026) & (L)
Figure 43. iPSC-Derived Hepatocyte-Like Cells Consumed in Liver Disease Modeling
Figure 44. Global iPSC-Derived Hepatocyte-Like Cells Market: Liver Disease Modeling (2021-2026) & (L)
Figure 45. iPSC-Derived Hepatocyte-Like Cells Consumed in RNA and Gene Therapy Delivery Studies
Figure 46. Global iPSC-Derived Hepatocyte-Like Cells Market: RNA and Gene Therapy Delivery Studies (2021-2026) & (L)
Figure 47. iPSC-Derived Hepatocyte-Like Cells Consumed in Regenerative Medicine Research
Figure 48. Global iPSC-Derived Hepatocyte-Like Cells Market: Regenerative Medicine Research (2021-2026) & (L)
Figure 49. iPSC-Derived Hepatocyte-Like Cells Consumed in Basic Liver Biology Research
Figure 50. Global iPSC-Derived Hepatocyte-Like Cells Market: Basic Liver Biology Research (2021-2026) & (L)
Figure 51. Global iPSC-Derived Hepatocyte-Like Cells Sale Market Share by Application (2025)
Figure 52. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Application in 2025
Figure 53. iPSC-Derived Hepatocyte-Like Cells Sales by Company in 2025 (L)
Figure 54. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Company in 2025
Figure 55. iPSC-Derived Hepatocyte-Like Cells Revenue by Company in 2025 ($ millions)
Figure 56. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Company in 2025
Figure 57. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Geographic Region (2021-2026)
Figure 58. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Geographic Region in 2025
Figure 59. Americas iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 60. Americas iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 61. APAC iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 62. APAC iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 63. Europe iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 64. Europe iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 65. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales 2021-2026 (L)
Figure 66. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Revenue 2021-2026 ($ millions)
Figure 67. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country in 2025
Figure 68. Americas iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country (2021-2026)
Figure 69. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 70. Americas iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 71. United States iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 72. Canada iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 73. Mexico iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 74. Brazil iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 75. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Region in 2025
Figure 76. APAC iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Region (2021-2026)
Figure 77. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 78. APAC iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 79. China iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 80. Japan iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 81. South Korea iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 82. Southeast Asia iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 83. India iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 84. Australia iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 85. China Taiwan iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 86. Europe iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country in 2025
Figure 87. Europe iPSC-Derived Hepatocyte-Like Cells Revenue Market Share by Country (2021-2026)
Figure 88. Europe iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 89. Europe iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 90. Germany iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 91. France iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 92. UK iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 93. Italy iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 94. Russia iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 95. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Country (2021-2026)
Figure 96. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Type (2021-2026)
Figure 97. Middle East & Africa iPSC-Derived Hepatocyte-Like Cells Sales Market Share by Application (2021-2026)
Figure 98. Egypt iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 99. South Africa iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 100. Israel iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 101. Turkey iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 102. GCC Countries iPSC-Derived Hepatocyte-Like Cells Revenue Growth 2021-2026 ($ millions)
Figure 103. Manufacturing Cost Structure Analysis of iPSC-Derived Hepatocyte-Like Cells in 2026
Figure 104. Manufacturing Process Analysis of iPSC-Derived Hepatocyte-Like Cells
Figure 105. Industry Chain Structure of iPSC-Derived Hepatocyte-Like Cells
Figure 106. Channels of Distribution
Figure 107. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Forecast by Region (2027-2032)
Figure 108. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share Forecast by Region (2027-2032)
Figure 109. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share Forecast by Type (2027-2032)
Figure 110. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share Forecast by Type (2027-2032)
Figure 111. Global iPSC-Derived Hepatocyte-Like Cells Sales Market Share Forecast by Application (2027-2032)
Figure 112. Global iPSC-Derived Hepatocyte-Like Cells Revenue Market Share Forecast by Application (2027-2032)
